• Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
XU Mingqing, Email: xumingqing0018@163.com
Export PDF Favorites Scan Get Citation

Objective To summarize the research progress in the study of the diagnostic function of humoral circular RNAs in human diseases.Methods The research progress was summarized by reading relevant literatures on the diagnostic function of humoral circular RNAs in human disease at home and abroad.Results As endogenous circular RNA molecules, circular RNAs were found to be related to a variety of diseases due to their stable structures, conserved sequences, diverse functions, and tissue cell specificity. Recent studies had found that circular RNAs could be secreted into body fluids, such as blood, saliva, urine, gastric juice, seminal plasma, and so on. They could also exist in body fluids stably. In addition, circular RNAs were found that was related to the diagnosis of various diseases, including cardiovascular diseases, nervous system diseases, autoimmune diseases, various carcinomas and metabolic diseases, and so on. As a consequence, circular RNAs might be important biomarkers for non-invasive detection of human diseases.Conclusions Recent researches have found that circular RNA is related to the diagnosis of various diseases. Therefore, the in-depth study of the relationship between humoral circular RNAs and the diagnosis of diseases is conducive to the development of non-invasive diagnostic markers of clinical diseases, which is of great significance for the non-invasive diagnosis of diseases.

Citation: REN Shengsheng, XU Liangliang, ZHANG Ming, XU Mingqing. Advances in the diagnostic function of humoral circular RNAs in human diseases. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2019, 26(5): 611-619. doi: 10.7507/1007-9424.201811022 Copy

  • Previous Article

    Research progress on relationship between NLRP3 inflammasome and acute pancreatitis
  • Next Article

    Advanced research on programmed death 1 and its ligand inhibitor in colorectal cancer